| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Correspondence to: David M. Mannino, MD, FCCP, Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-17, Atlanta, GA 30333; e-mail: dmmb{at}cdc.gov
COPD continues to cause a heavy health and economic burden both in the United States and around the world. Some of the risk factors for COPD are well-known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions, such as why < 20% of smokers develop significant airway obstruction, remain. Precise definitions of COPD vary and are frequently dependent on an accurate diagnosis of the problem by a physician. These differences in the definition of COPD can have large effects on the estimates of COPD in the population. Furthermore, evidence that COPD represents several different disease processes with potentially different interventions continues to emerge. In most of the world, COPD prevalence and mortality are still increasing and likely will continue to rise in response to increases in smoking, particularly by women and adolescents. Resources aimed at smoking cessation and prevention, COPD education and early detection, and better treatment will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality. ;126>
Key Words: COPD • epidemiology • mortality • prevalence • risk factors
This article has been cited by other articles:
|
|
 |
|
  C. C. Greene, K. A. Bradley, C. L. Bryson, D. K. Blough, L. E. Evans, E. M. Udris, and D. H. Au The Association Between Alcohol Consumption and Risk of COPD Exacerbation in a Veteran Population Chest, October 1, 2008; 134(4): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Caballero, C. A. Torres-Duque, C. Jaramillo, F. Bolivar, F. Sanabria, P. Osorio, C. Orduz, D. P. Guevara, and D. Maldonado Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study) Chest, February 1, 2008; 133(2): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laurin, K. L. Lavoie, S. L. Bacon, G. Dupuis, G. Lacoste, A. Cartier, and M. Labrecque Sex Differences in the Prevalence of Psychiatric Disorders and Psychological Distress in Patients With COPD Chest, July 1, 2007; 132(1): 148 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-P. Ng, M. Niti, W.-C. Tan, Z. Cao, K.-C. Ong, and P. Eng Depressive Symptoms and Chronic Obstructive Pulmonary Disease: Effect on Mortality, Hospital Readmission, Symptom Burden, Functional Status, and Quality of Life Arch Intern Med, January 8, 2007; 167(1): 60 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marsh, S. Aldington, P. Shirtcliffe, M. Weatherall, and R. Beasley Smoking and COPD: what really are the risks? Eur. Respir. J., October 1, 2006; 28(4): 883 - 884. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Mentzelopoulos, J. Sigala, C. Roussos, and S. G. Zakynthinos Static pressure-volume curves and body posture in severe chronic bronchitis Eur. Respir. J., July 1, 2006; 28(1): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-P. Boulet, C. Lemiere, F. Archambault, G. Carrier, M. C. Descary, and F. Deschesnes Smoking and Asthma: Clinical and Radiologic Features, Lung Function, and Airway Inflammation Chest, March 1, 2006; 129(3): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Chen and G. L. Narsavage Factors related to chronic obstructive pulmonary disease readmission in Taiwan. West J Nurs Res, February 1, 2006; 28(1): 105 - 124. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Tarlo Cough: Occupational and Environmental Considerations: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 186S - 196S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Adlowitz, S. Sethi, P. Cullen, B. Adler, and T. F. Murphy Human Antibody Response to Outer Membrane Protein G1a, a Lipoprotein of Moraxella catarrhalis Infect. Immun., October 1, 2005; 73(10): 6601 - 6607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Holguin, E. Folch, S. C. Redd, and D. M. Mannino Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001 Chest, October 1, 2005; 128(4): 2005 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Kiri, N. B. Pride, J. B. Soriano, and J. Vestbo Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Results from Two Observational Designs Free of Immortal Time Bias Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 460 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gunen, S. S. Hacievliyagil, F. Kosar, L. C. Mutlu, G. Gulbas, E. Pehlivan, I. Sahin, and O. Kizkin Factors affecting survival of hospitalised patients with COPD Eur. Respir. J., August 1, 2005; 26(2): 234 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Murphy, A. L. Brauer, B. J. B. Grant, and S. Sethi Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease: Burden of Disease and Immune Response Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 195 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Mentzelopoulos, C. Roussos, and S. G. Zakynthinos Prone position improves expiratory airway mechanics in severe chronic bronchitis Eur. Respir. J., February 1, 2005; 25(2): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Hillier, T. P. Toma, and C. E. Gillbe Bronchoscopic Lung Volume Reduction in Patients with Severe Emphysema: Anesthetic Management Anesth. Analg., December 1, 2004; 99(6): 1610 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Lapperre, J. B. Snoeck-Stroband, M. M.E. Gosman, J. Stolk, J. K. Sont, D. F. Jansen, H. A.M. Kerstjens, D. S. Postma, and P. J. Sterk Dissociation of Lung Function and Airway Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.R. Curtis, R.A. Engelberg, E.L. Nielsen, D.H. Au, and D.L. Patrick Patient-physician communication about end-of-life care for patients with severe COPD Eur. Respir. J., August 1, 2004; 24(2): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Butler, W.-P. Koh, H.-P. Lee, M. C. Yu, and S. J. London Dietary Fiber and Reduced Cough with Phlegm: A Cohort Study in Singapore Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Silva, D. L. Sherrill, S. Guerra, and R. A. Barbee Asthma as a Risk Factor for COPD in a Longitudinal Study Chest, July 1, 2004; 126(1): 59 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. D'Alonzo Jr. Levalbuterol in the Treatment of Patients With Asthma and Chronic Obstructive Lung Disease J Am Osteopath Assoc, July 1, 2004; 104(7): 288 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.N. de Melo, P. Ernst, and S. Suissa Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Eur. Respir. J., May 1, 2004; 23(5): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Dougherty, B. L Didur, and L. S Aboussouan Long-Acting Inhaled {beta}2-Agonists for Stable COPD Ann. Pharmacother., September 1, 2003; 37(9): 1247 - 1255. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
